Detalhe da pesquisa
1.
LOX-1 mediates inflammatory activation of microglial cells through the p38-MAPK/NF-κB pathways under hypoxic-ischemic conditions.
Cell Commun Signal
; 21(1): 126, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37268943
2.
Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1-Related Microglial Activation in Neonatal Hypoxic-Ischemic Encephalopathy: Morphologic Consideration.
Am J Pathol
; 191(7): 1303-1313, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33964218
3.
LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1) Deletion Has Protective Effects on Stroke in the Genetic Background of Stroke-Prone Spontaneously Hypertensive Rat.
Stroke
; 51(6): 1835-1843, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32397936
4.
A Pilot Study of Soluble Form of LOX-1 as a Novel Biomarker for Neonatal Hypoxic-Ischemic Encephalopathy.
J Pediatr
; 206: 49-55.e3, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30553539
5.
LOX-1 is a novel therapeutic target in neonatal hypoxic-ischemic encephalopathy.
Am J Pathol
; 184(6): 1843-52, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24731447
6.
Adapting pediatric health care responses to the COVID-19 pandemic in Japan: A clinical perspective.
Glob Health Med
; 4(4): 242-246, 2022 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36119789